Ancora Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-1,479
| Closed | -$13K | – | 687 |
|
|
2017
Q2 | $13K | Hold |
1,479
| – | – | ﹤0.01% | 624 |
|
|
2017
Q1 | $39K | Hold |
1,479
| – | – | ﹤0.01% | 615 |
|
|
2016
Q4 | $65K | Sell |
1,479
-1,100
| -43% | -$48.3K | ﹤0.01% | 735 |
|
|
2016
Q3 | $41K | Hold |
2,579
| – | – | ﹤0.01% | 521 |
|
|
2016
Q2 | $85K | Hold |
2,579
| – | – | 0.01% | 499 |
|
|
2016
Q1 | $72K | Hold |
2,579
| – | – | 0.01% | 481 |
|
|
2015
Q4 | $120K | Sell |
2,579
-450
| -15% | -$20.9K | 0.02% | 470 |
|
|
2015
Q3 | $542K | Hold |
3,029
| – | – | 0.07% | 291 |
|
|
2015
Q2 | $433K | Buy |
+3,029
| New | +$433K | 0.05% | 344 |
|
|
2015
Q1 | – | Sell |
-1,550
| Closed | -$277K | – | 382 |
|
|
2014
Q4 | $277K | Buy |
+1,550
| New | +$277K | 0.03% | 406 |
|